| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11010-007-9466-X |
| P8608 | Fatcat ID | release_iy4l4q34gjctrgl767q33wzvey |
| P698 | PubMed publication ID | 17458518 |
| P2093 | author name string | Ming Zhou | |
| Cong Peng | |||
| Xiao Ling Li | |||
| Li Ming Zhang | |||
| Gui Yuan Li | |||
| Shou Rong Shen | |||
| Hua Ying Liu | |||
| P2860 | cites work | Molecular characterization of celtix-1, a bromodomain protein interacting with the transcription factor interferon regulatory factor 2 | Q24290379 |
| Regulation of the PH-domain-containing tyrosine kinase Etk by focal adhesion kinase through the FERM domain | Q24291190 | ||
| The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain | Q24293463 | ||
| Regulation of transcription by the heterogeneous nuclear ribonucleoprotein E1B-AP5 is mediated by complex formation with the novel bromodomain-containing protein BRD7 | Q24337326 | ||
| Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase | Q24682825 | ||
| The Hedgehog and Wnt signalling pathways in cancer | Q28189485 | ||
| Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways | Q28571378 | ||
| Researching a novel NPC-related candidate suppressor gene BRD7 by two-dimensional gel electrophoresis and MALDI-TOF-MS | Q30980491 | ||
| Screening of BRD7 interacting proteins by yeast two-hybrid system | Q33365053 | ||
| The dual role of cytoskeletal anchor proteins in cell adhesion and signal transduction | Q33833342 | ||
| BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways | Q34320007 | ||
| The Raf/MEK/ERK pathway: new concepts of activation. | Q34454912 | ||
| Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. | Q35023644 | ||
| Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion | Q36436367 | ||
| Gene expression profiling of nasopharyngeal carcinoma reveals the abnormally regulated Wnt signaling pathway | Q38309301 | ||
| Ternary complex factors: growth factor regulated transcriptional activators | Q40757584 | ||
| Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response. | Q41093962 | ||
| Mitogen-activated protein kinase/extracellular signal-regulated protein kinase activation by oncogenes, serum, and 12-O-tetradecanoylphorbol-13-acetate requires Raf and is necessary for transformation | Q41481475 | ||
| Beta-catenin: a key mediator of Wnt signaling | Q41732761 | ||
| Signal transduction through MAP kinase cascades | Q41750250 | ||
| Both ERK and Wnt/beta-catenin pathways are involved in Wnt3a-induced proliferation | Q42472178 | ||
| Differential signaling pathways are activated in the Epstein-Barr virus-associated malignancies nasopharyngeal carcinoma and Hodgkin lymphoma | Q45605928 | ||
| Chromosomal aberrations in nasopharyngeal carcinoma analyzed by comparative genomic hybridization. | Q53423354 | ||
| Loss of heterozygosity on chromosome arm 3p in nasopharyngeal carcinoma | Q71769244 | ||
| Genome-wide allelotype analysis of sporadic primary nasopharyngeal carcinoma from southern China | Q73191186 | ||
| Expression of c-erbB receptors, heregulin and oestrogen receptor in human breast cell lines | Q74081713 | ||
| Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4 | Q74462924 | ||
| Signaling from G-protein-coupled receptors to mitogen-activated protein (MAP)-kinase cascades | Q77322545 | ||
| Downregulation and abnormal expression of E-cadherin and beta-catenin in nasopharyngeal carcinoma: close association with advanced disease stage and lymph node metastasis | Q77340409 | ||
| Loss of heterozygosity on chromosome 14 in nasopharyngeal carcinoma | Q77354036 | ||
| Detection of recurrent chromosomal gains and losses in primary nasopharyngeal carcinoma by comparative genomic hybridisation | Q77995454 | ||
| A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma | Q79787068 | ||
| Detailed deletion mapping on the short arm of chromosome-3 in nasopharyngeal carcinomas | Q84089664 | ||
| P433 | issue | 1-2 | |
| P304 | page(s) | 141-149 | |
| P577 | publication date | 2007-04-26 | |
| P1433 | published in | Molecular and Cellular Biochemistry | Q1573176 |
| P1476 | title | BRD7 suppresses the growth of Nasopharyngeal Carcinoma cells (HNE1) through negatively regulating beta-catenin and ERK pathways | |
| P478 | volume | 303 |
| Q46493497 | A genomic screen for angiosuppressor genes in the tumor endothelium identifies a multifaceted angiostatic role for bromodomain containing 7 (BRD7). |
| Q99413660 | BRD4/8/9 are prognostic biomarkers and associated with immune infiltrates in hepatocellular carcinoma |
| Q55119106 | BRD7 inhibits the Warburg effect and tumor progression through inactivation of HIF1α/LDHA axis in breast cancer. |
| Q24303120 | BRD7 is a candidate tumour suppressor gene required for p53 function |
| Q33684240 | BRD7 mediates hyperglycaemia-induced myocardial apoptosis via endoplasmic reticulum stress signalling pathway |
| Q38760091 | BRD7 plays an anti-inflammatory role during early acute inflammation by inhibiting activation of the NF-кB signaling pathway |
| Q33838482 | BRD7 regulates XBP1s' activity and glucose homeostasis through its interaction with the regulatory subunits of PI3K |
| Q47414450 | BRD7 regulates the insulin-signaling pathway by increasing phosphorylation of GSK3β. |
| Q89579657 | BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition |
| Q26751298 | BRD7: a novel tumor suppressor gene in different cancers |
| Q37086000 | Bromodomain-containing protein 7 (BRD7) as a potential tumor suppressor in hepatocellular carcinoma |
| Q24308923 | Ceap/BLOS2 interacts with BRD7 and selectively inhibits its transcription-suppressing effect on cellular proliferation-associated genes |
| Q64941197 | Clinical significance of bromodomain-containing protein 7 and its association with tumor progression in prostate cancer. |
| Q54933469 | Design and synthesis of potent and selective inhibitors of BRD7 and BRD9 bromodomains |
| Q28542858 | Inhibition of TMEM16A expression suppresses growth and invasion in human colorectal cancer cells |
| Q38457229 | Integrating ChIP-sequencing and digital gene expression profiling to identify BRD7 downstream genes and construct their regulating network |
| Q34514258 | Knockout of BRD7 results in impaired spermatogenesis and male infertility |
| Q34708453 | LPLUNC1 inhibits nasopharyngeal carcinoma cell growth via down-regulation of the MAP kinase and cyclin D1/E2F pathways |
| Q38790987 | Low concentration of formononetin stimulates the proliferation of nasopharyngeal carcinoma cell line CNE2 by upregulating bcl-2 and p-ERK1/2 expression |
| Q38856137 | MicroRNA-410 promotes cell proliferation by targeting BRD7 in non-small cell lung cancer |
| Q27704896 | NMR Fragment Screening Hit Induces Plasticity of BRD7/9 Bromodomains |
| Q34611577 | Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis |
| Q92800638 | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents |
| Q34069831 | Polybromo-associated BRG1-associated factor components BRD7 and BAF180 are critical regulators of p53 required for induction of replicative senescence |
| Q54280630 | Prognostic relevance of BRD7 expression in colorectal carcinoma. |
| Q33367808 | Promoter methylation inhibits BRD7 expression in human nasopharyngeal carcinoma cells |
| Q38795544 | Pyruvate dehydrogenase B promoted the growth and migration of the nasopharyngeal carcinoma cells. |
| Q34614284 | SPLUNC1 regulates cell progression and apoptosis through the miR-141-PTEN/p27 pathway, but is hindered by LMP1. |
| Q37260036 | Signaling Transduction Network Mediated by Tumor Suppressor/Susceptibility Genes in NPC. |
| Q36925822 | Structural basis of protein-protein interaction studied by NMR. |
| Q24316908 | TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells |
| Q33917573 | Targeting the anaphase-promoting complex/cyclosome (APC/C)- bromodomain containing 7 (BRD7) pathway for human osteosarcoma |
| Q99629107 | The BRD7-P53-SLC25A28 axis regulates ferroptosis in hepatic stellate cells |
| Q39455273 | The interactions between MicroRNA-200c and BRD7 in endometrial carcinoma |
| Q37117156 | The role of BRD7 in embryo development and glucose metabolism |
| Q42009542 | Tumor suppressor bromodomain-containing protein 7 cooperates with Smads to promote transforming growth factor-β responses |
| Q36905617 | XIAP-associating factor 1, a transcriptional target of BRD7, contributes to endothelial cell senescence |
| Q55449419 | [Expression and clinical significance of bromodomain-containing protein 7 in non-small cell lung cancer]. |
| Q36775043 | miR-141 is involved in BRD7-mediated cell proliferation and tumor formation through suppression of the PTEN/AKT pathway in nasopharyngeal carcinoma |
Search more.